Kids with HIV get uninterrupted drug access in new study
Disease control
Recruiting now
This study offers continued access to HIV medications for up to 350 children and teens who completed a previous Gilead HIV treatment study. Participants may stay on their current drug or switch to a newer combination pill. The main goal is to ensure they keep receiving treatment …
Phase: PHASE4 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Apr 26, 2026 20:00 UTC